{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:01:03Z","timestamp":1793145663192,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To describe the prevalence, trends, and patterns in use of antidiabetic medications to treat hyperglycemia and insulin resistance before and during pregnancy in a large U.S. cohort of insured pregnant women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Pregnancies resulting in live births were identified (N=437,950) from 2001 to 2007 among 372,543 females 12\u201350 years of age at delivery from 10 health maintenance organizations participating in the Medication Exposure in Pregnancy Risk Evaluation Program. Information for these descriptive analyses, including all antidiabetic medications dispensed during this period, was extracted from electronic health records and newborn birth certificates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A little more than 1% (1.21%) of deliveries were to women dispensed antidiabetic medication in the 120 days before pregnancy. Use of antidiabetic medications before pregnancy increased from 0.66% of deliveries in 2001 to 1.66% of deliveries in 2007 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001) because of an increase in metformin use. Most women using metformin before pregnancy had a diagnosis code for polycystic ovaries or female infertility (67.2%), whereas only 13.6% had a diagnosis code for diabetes. The use of antidiabetic medications during the second or third trimester of pregnancy increased from 2.8% of deliveries in 2001 to 3.6% in 2007 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001). Approximately two thirds (68%) of women using metformin before pregnancy did not use any antidiabetic medications during pregnancy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Antidiabetic medication use before and during pregnancy increased from 2001 to 2007, possibly because of increasing prevalence of gestational diabetes mellitus, type 1 and type 2 diabetes, and other conditions associated with insulin resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE:<\/jats:title>\n                    <jats:p>III<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0b013e318278ce86","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T14:40:27Z","timestamp":1444747227000},"page":"106-114","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Prevalence, Trends, and Patterns of Use of Antidiabetic Medications Among Pregnant Women, 2001-2007"],"prefix":"10.1097","volume":"121","author":[{"given":"Jean M.","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsay A.","family":"Avalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Beaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki Y.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Dublin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamala A.","family":"Pawloski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha A.","family":"Raebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sengwee","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Q.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigal","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thushi","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hampp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek A.","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela E.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Craig","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20260317","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ajmg.c.30309","article-title":"We dont know what we dont study: the case for research on medication effects in pregnancy.","volume":"157","author":"Parisi","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R2-17-20260317","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajog.2004.04.025","article-title":". Prescription drug use in pregnancy.","volume":"191","author":"Andrade","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R3-17-20260317","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1464-5491.2002.00665.x","article-title":". St Vincents declaration 10 years on: outcomes of diabetic pregnancies.","volume":"19","author":"Platt","year":"2002","journal-title":"Diabetic Med"},{"key":"R4-17-20260317","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1210\/jc.2009-1231","article-title":"Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis.","volume":"94","author":"Balsells","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-17-20260317","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.2337\/dc07-s206","article-title":"Increasing prevalence of gestational diabetes mellitus: a public health perspective.","volume":"30","author":"Ferrara","year":"2007","journal-title":"Diabetes Care"},{"key":"R6-17-20260317","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/01.AOG.0000113623.18286.20","article-title":"An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000.","volume":"103","author":"Ferrara","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R7-17-20260317","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2337\/diacare.28.3.579","article-title":"Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program.","volume":"28","author":"Dabelea","year":"2005","journal-title":"Diabetes Care"},{"key":"R8-17-20260317","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ajog.2007.11.017","article-title":"Gestational diabetes in the United States: temporal trends 1989 through 2004.","volume":"198","author":"Getahun","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R9-17-20260317","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2337\/dc07-2345","article-title":"Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a raciallyethnically diverse population of pregnant women, 1999-2005.","volume":"31","author":"Lawrence","year":"2008","journal-title":"Diabetes Care"},{"key":"R10-17-20260317","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2337\/diacare.29.02.06.dc05-1482","article-title":"Trends in deliveries, prenatal care, and obstetrical complications in women with pregestational diabetes: a population-based study in Ontario, Canada, 1996-2001.","volume":"29","author":"Feig","year":"2006","journal-title":"Diabetes Care"},{"key":"R11-17-20260317","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2337\/dc09-1801","article-title":". Diabetes trends among delivery hospitalizations in the U.S., 1994-2004.","volume":"33","author":"Albrecht","year":"2010","journal-title":"Diabetes Care"},{"key":"R12-17-20260317","first-page":"A120","article-title":"Trends in selected chronic conditions and behavioral risk factors among women of reproductive age, behavioral risk factor surveillance system, 2001-2009.","volume":"8","author":"Hayes","year":"2011","journal-title":"Prev Chronic Dis"},{"key":"R13-17-20260317","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s10995-011-0902-x","article-title":". Medication exposure in pregnancy risk evaluation program.","volume":"16","author":"Andrade","year":"2012","journal-title":"Matern Child Health J"},{"key":"R15-17-20260317","first-page":"1","article-title":". Births: final data for 2007.","volume":"58","author":"Martin","year":"2010","journal-title":"Natl Vital Stat Rep"},{"key":"R16-17-20260317","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/pds.1100","article-title":"Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data.","volume":"14","author":"Raebel","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R17-17-20260317","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/aje\/kwm367","article-title":"Sensitivity and specificity of computerized algorithms to classify gestational periods in the absence of information on date of conception.","volume":"167","author":"Toh","year":"2008","journal-title":"Am J Epidemiol"},{"key":"R18-17-20260317","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis.","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"key":"R20-17-20260317","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.ftd.0000184161.52573.0e","article-title":"Population pharmacokinetics of metformin in late pregnancy.","volume":"28","author":"Charles","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R21-17-20260317","first-page":"179","article-title":"The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis.","volume":"10","author":"Gutzin","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"R22-17-20260317","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.fertnstert.2006.02.098","article-title":"Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis.","volume":"86","author":"Gilbert","year":"2006","journal-title":"Fertil Steril"},{"key":"R23-17-20260317","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus insulin for the treatment of gestational diabetes.","volume":"358","author":"Rowan","year":"2008","journal-title":"N Engl J Med"},{"key":"R24-17-20260317","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2337\/dc09-2095","article-title":"Prevalence and timing of postpartum glucose testing and sustained glucose dysregulation after gestational diabetes mellitus.","volume":"33","author":"Lawrence","year":"2010","journal-title":"Diabetes Care"},{"key":"R25-17-20260317","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2337\/dc08-1184","article-title":"Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: a report from the Translating Research Into Action for Diabetes (TRIAD) Study.","volume":"32","author":"Ferrara","year":"2009","journal-title":"Diabetes Care"},{"key":"R26-17-20260317","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/pds.2217","article-title":". Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy.","volume":"20","author":"Andrade","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R27-17-20260317","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/jama.297.24.2716","article-title":". Incidence of diabetes in youth in the United States.","volume":"297","author":"Dabelea","year":"2007","journal-title":"JAMA"},{"key":"R28-17-20260317","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1542\/peds.2006-0690","article-title":". The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study.","volume":"118","author":"Liese","year":"2006","journal-title":"Pediatrics"},{"key":"R29-17-20260317","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc10-0719","article-title":". International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy.","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care"},{"key":"R30-17-20260317","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.2337\/dc10-1445","article-title":"Clinical outcomes of pregnancies complicated by mild gestational diabetes mellitus differ by combinations of abnormal oral glucose tolerance test values.","volume":"33","author":"Black","year":"2010","journal-title":"Diabetes Care"},{"key":"R31-17-20260317","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1464-5491.2011.03236.x","article-title":"The implications of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria for gestational diabetes.","volume":"28","author":"Holt","year":"2011","journal-title":"Diabetic Med"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201301000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:00:27Z","timestamp":1773709227000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201301000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e318278ce86","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}